The forces pushing the country toward value-based care will continue regardless of who is in control in Washington, DC, said L. Patrick James, MD, chief clinical officer for health plans and policy, medical affairs, for Quest Diagnostics.
The forces pushing the country toward value-based care will continue regardless of who is in control in Washington, DC, said L. Patrick James, MD, chief clinical officer for health plans and policy, medical affairs, for Quest Diagnostics.
Transcript
Why do you think physicians and health plan executives so strongly beiieve that a transition to value-based care will continue regardless of who is in control of Washington, DC?
There's forces just beyond the political—that's certainly important, right, but the economic forces are probably a major driver. But there's convergence of other things, such as transparency issues—not only price but outcomes. And now that many of us that are employed are in high-deductible plans, we have more skin in the game economically.
And so I think what employers are doing, what people are feeling in terms of their own expenses, and the availability of better information, certainly on price, but quality information is coming also. So I think this will continue to drive the movement toward value.
Are there concerns that HHS Secretary Tom Price's dislike of mandatory payment pilots could slow the progression toward value-based payments?
I attended some sessions yesterday at AHIP [Institute & Expo] and Dr Patrick Conway, chief medical officer of CMS, he avoided talking about what is going on politically right now, but he just reaffirmed that there's just so many things underway now in terms of the forces driving this. If Secretary Price has certain opinions about that, they certainly would get debated and aired in the political forum, but I think many people believe—I heard it over and over again yesterday, too, whether it was Joe Swedish of Anthem or Dr Eric Topol or former Governor Mike Leavitt—I think most experts in the area and all of us in the trenches, feel like these forces will continue. There may be some bumps along the road, but it's probably going to continue because the forces are so strong.
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
It Take a Village in Cancer Care: A Q&A With David Nguyen, MD
July 23rd 2025David Nguyen, MD, medical oncologist with Tufts Medicine and Lowell General Hospital, discusses the evolving landscape of advanced cancer treatments like chimeric antigen receptor T-cell therapy and bispecific antibodies
Read More
Best of Managed Care Cast: Top 5 Episodes From the First Half of 2025
July 18th 2025These interviews are the top episodes, by listens, from among the 21 podcast episodes The American Journal of Managed Care® produced over the first half of 2025. Give them all another listen, and perhaps learn something new.
Read More